Suchergebnisse - "Pisano, Carmela"

PubPharm (133)

1

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

2

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype : A Randomized Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Lorusso, D. | Raspagliesi, F. | Ronzulli, D. | +20

3

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations

enthalten in: JAMA network open | 2024

von Schouten, P. | Schmidt, S. | Becker, K. | +20

4

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy : The MITO 44 study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Tuninetti, V. | Virano, E. | Salutari, V. | +21

5

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo : Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

enthalten in: Gynecologic oncology | 2024

von Pothuri, B. | Han, S. | Chase, D. | +23

6

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Oaknin, A. | Gladieff, L. | Martínez-García, J. | +117

7

MITO39 : Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study

enthalten in: Cancers | 2023

von Turinetto, M. | Ricotti, A. | Marchetti, C. | +18

8

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab

enthalten in: Clinical pharmacology and therapeutics | 2023

von Polano, M. | Bedon, L. | Dal Bo, M. | +19

9

The role of immunotherapy treatment in non-clear cell renal cell carcinoma : An analysis of the literature

enthalten in: Critical reviews in oncology/hematology | 2023

von Ventriglia, J. | Passarelli, A. | Pisano, C. | +9

10

Safety of PARP inhibitors as maintenance therapy in ovarian cancer

enthalten in: Expert opinion on drug safety | 2023

von Cecere, S. | Casartelli, C. | Forte, M. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]